Mark:

TREATMENTMAP - WHOLE EXOME

Status Date:

03-27-2015

Registration Number:

N/A

Goods and Services:

Medical diagnostic equipment for molecular testing in cancer diagnostics, in particular cancer genomic testing and testing of genomic changes, in particular next generation sequencing (NGS) laboratory equipment, in particular next generation sequencing laboratory instruments for clinical and medical use and automated decision support tools for diagnostic and therapeutic application; surgical, medical, dental and veterinary apparatus and instruments; testing apparatus for medical purposes; surgical implants; physical exercise apparatus for medical purposes Data collection for research, analytical and clinical purposes, in particular the collection and systematic sorting of patient��s specific molecular, genomic and/or clinical data, in particular relating to genomic changes, in particular relating to cancer genomic changes; providing medical information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; scientific clinical studies; data collection for research and analytical purposes, in particular the collection of mathematical and statistical data, clinical data, patient��s genomic data and data of clinical studies relating to patient��s clinical responses to drug treatments and treatment regimes; compiling data for research and analytical purposes in the field of medical science and diagnostics, in particular compiling patient specific molecular and genomic data, in particular cancer genomic data; scientific, technical and research services for medical purposes in the field of medical diagnostic and optimization of treatment regimes; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing services in the field of next generation sequencing (NGS) including the analysis and interpretation of the thereby obtained data, in particular the analysis and interpretation of data obtained from cancer patients, in particular the analysis and interpretation of the patient��s genomic changes that contribute to patient��s unique cancer disease; providing an online database comprised of medical, pharmaceutical, biological and/or genomic information for medical and diagnostic purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and/or genomic information for scientific research, analytical and clinical purposes; providing an online searchable database in the fields of cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient��s specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment, in particular in the field of cancer diagnosis and therapy; design and development of databases featuring biomarker data; providing an online searchable database for medical, diagnostic and clinical use as well as for the analysis and optimization of treatment protokolls; Software as a Service (SAAS) services featuring software for providing information for patient��s treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, in particular designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others Providing online databases featuring medical, pharmaceutical and genomic information; pharmaceutical consulting services in pharmaceuticals and genetics in relating to patient medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the filed of cancer diagnostics and cancer therapy; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, in particular information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatments and treatment protocols; consulting services in the fields of pharmaceuticals and genetics, in particular conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; genomic and molecular medical testing for diagnostic or treatment purposes, in particular cancer diagnostics; diagnostic services for cancer patients and patients with other diseases and disorders; cancer genomic and molecular testing, in particular by using next generation sequencing methods, in particular the analysis of genomic changes by next generation sequencing of DNA samples obtained by patients; collection and analysis of cancer-associated genetic and treatment information; medical data and information processing, storage and communication to physicians and healthcare professionals; providing an information platform with information about patient��s individual cancer profile and genomic changes for enabling physicians and healthcare professionals to optimize treatments in clinical practice

Class:

Medical services

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Business Name:

CLARK & ELBING LLP